Sector Protalix BioTherapeutics, Inc.

Aandelen

PLX

US74365A3095

Farmaceutische producten

Beurs gesloten - 22:00:00 23-09-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,800 USD -1,41% Intraday-grafiek van Protalix BioTherapeutics, Inc. +4,48% +55,56%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-1,41%+4,48%+17,65%+29,03%+55,56%+42,86%+68,67%+104,38%-50,88% 226 mln.
-1,64%+1,16%-8,32%+3,97%+7,10%+54,09%+109,07%+395,73%+1.318,17% 1.026 mld.
-0,01%+0,71%-0,40%+12,59%+30,07%+52,44%+67,71%+63,27%+126,56% 649 mld.
-0,05%+0,98%+0,05%+12,92%+16,01%+19,08%+73,55%+146,91%+307,94% 468 mld.
-0,48%+0,47%-2,02%+9,31%+10,57%+39,63%+45,42%+6,61%+49,90% 352 mld.
+0,63%+2,29%-6,37%-4,55%+8,28%+21,31%+28,30%+54,21%+52,15% 271 mld.
-0,70%-0,48%+2,13%-11,09%-10,31%+10,33%+10,49%+39,83%+142,56% 256 mld.
-1,01%+7,90%-7,57%+17,03%+24,07%+41,59%+51,70%+88,84%+132,32% 220 mld.
-0,85%+2,50%+3,59%+21,05%+23,33%+32,32%+101,80%+111,15%+86,03% 188 mld.
-1,76%-11,40%-17,29%-20,56%-23,90%-33,39%-61,16%-22,89%+67,12% 170 mld.
+0,90%+2,62%+0,39%+14,00%+13,17%+16,78%-13,80%-36,23%-17,75% 161 mld.
+0,26%+0,60%-5,79%+10,23%+13,89%+35,98%+47,72%+178,97%+469,72% 131 mld.
-1,77%-3,85%-8,74%+10,12%+13,37%+36,16%+3,82%+0,86%+8,27% 125 mld.
-0,05%-2,86%-6,60%-0,60%-11,62%-8,04%-28,77%-10,86%+8,17% 99,8 mld.
-0,61%-1,32%-0,82%-3,85%+2,77%+26,26%+22,09%+8,07%-8,17% 100 mld.
-1,42%-0,51%-4,82%-11,33%-19,33%-1,80%+54,69%+54,51%+445,83% 70,1 mld.
-1,39%-1,03%+1,52%+15,30%+21,72%+32,07%+23,43%+56,06%+21,57% 60,18 mld.
-0,43%+0,59%+1,75%+24,60%+33,29%+78,67%+6,50%+6,10%-44,70% 55,19 mld.
-1,29%+1,25%+5,43%+28,58%+36,35%+95,05%+280,59%+344,81%-23,60% 45,46 mld.
-0,31%+4,73%-4,52%-6,94%-23,48%-34,61%+3,45%-4,62%+176,23% 44,76 mld.
Gemiddelde -0,44%+1,62%-2,04%+7,49%+11,04%+27,84%+44,76%+79,28%+163,37% 224,57 mld.
Gewogen gemiddelde per kap. +0,30%+1,22%-3,83%+6,36%+11,21%+34,07%+57,68%+138,04%+400,77%
  1. Beurs
  2. Aandelen
  3. Koers PLX
  4. Sector Protalix BioTherapeutics, Inc.